(Press-News.org) Scientists in the US have developed a novel vaccination method that uses tiny gold particles to mimic a virus and carry specific proteins to the body's specialist immune cells.
The technique differs from the traditional approach of using dead or inactive viruses as a vaccine and was demonstrated in the lab using a specific protein that sits on the surface of the respiratory syncytial virus (RSV).
The results have been published today, 26 June, in IOP Publishing's journal Nanotechnology by a team of researchers from Vanderbilt University.
RSV is the leading viral cause of lower respiration tract infections, causing several hundred thousand deaths and an estimated 65 million infections a year, mainly in children and the elderly.
The detrimental effects of RSV come, in part, from a specific protein, called the F protein, which coats the surface of the virus. The protein enables the virus to enter into the cytoplasm of cells and also causes cells to stick together, making the virus harder to eliminate.
The body's natural defence to RSV is therefore directed at the F protein; however, up until now, researchers have had difficulty creating a vaccine that delivers the F protein to the specialised immune cells in the body. If successful, the F protein could trigger an immune response which the body could 'remember' if a subject became infected with the real virus.
In this study the researchers created exceptionally small gold nanorods, just 21 nanometres wide and 57 nanometres long, which were almost exactly the same shape and size as the virus itself. The gold nanorods were successfully coated with the RSV F proteins and were bonded strongly thanks to the unique physical and chemical properties of the nanorods themselves.
The researchers then tested the ability of the gold nanorods to deliver the F protein to specific immune cells, known as dendritic cells, which were taken from adult blood samples.
Dendritic cells function as processing cells in the immune system, taking the important information from a virus, such as the F protein, and presenting it to cells that can perform an action against them―the T cells are just one example of a cell that can take action.
Once the F protein-coated nanorods were added to a sample of dendritic cells, the researchers analysed the proliferation of T cells as a proxy for an immune response. They found that the protein-coated nanorods caused the T cells to proliferate significantly more compared to non-coated nanorods and just the F protein alone.
Not only did this prove that the coated-nanorods were capable of mimicking the virus and stimulating an immune response, it also showed that they were not toxic to human cells, offering significant safety advantages and increasing their potential as a real-life human vaccine.
Lead author of the study, Professor James Crowe, said: "A vaccine for RSV, which is the major cause of viral pneumonia in children, is sorely needed. This study shows that we have developed methods for putting RSV F protein into exceptionally small particles and presenting it to immune cells in a format that physically mimics the virus. Furthermore, the particles themselves are not infectious."
Due to the versatility of the gold nanorods, Professor Crowe believes that their potential use is not limited to RSV.
"This platform could be used to develop experimental vaccines for virtually any virus, and in fact other larger microbes such as bacteria and fungi.
"The studies we performed showed that the candidate vaccines stimulated human immune cells when they were interacted in the lab. The next steps to testing would be to test whether or not the vaccines work in vivo" Professor Crowe continued.
###
From 26 June 2013, this paper can be downloaded from http://iopscience.iop.org/0957-4484/24/29/295102
Notes to Editors
Contact
For further information, a full draft of the journal paper or contact with one of the researchers, contact IOP Press Officer, Michael Bishop:
Tel: 0117 930 1032
E-mail: Michael.bishop@iop.org
For more information on how to use the embargoed material above, please refer to our embargo policy.
IOP Publishing Journalist Area
The IOP Publishing Journalist Area gives journalists access to embargoed press releases, advanced copies of papers, supplementary images and videos. In addition to this, a weekly news digest is uploaded into the Journalist Area every Friday, highlighting a selection of newsworthy papers set to be published in the following week.
Login details also give free access to IOPscience, IOP Publishing's journal platform.
To apply for a free subscription to this service, please email Michael Bishop, IOP Press Officer, michael.bishop@iop.org, with your name, organisation, address and a preferred username.
Gold nanorod vaccine for respiratory syncytial virus
The published version of the paper "Gold nanorod vaccine for respiratory syncytial virus" (J W Stone et al 2013 Nanotechnology 24 295102) will be freely available online from 26 June 2013. It will be available from http://iopscience.iop.org/0957-4484/24/29/295102
Nanotechnology
Nanotechnology encompasses the understanding of the fundamental physics, chemistry, biology and technology of nanometre-scale objects.
IOP Publishing
IOP Publishing provides a range of journals, magazines, websites and services that enable researchers and research organisations to reach the widest possible audience for their research.
We combine the culture of a learned society with global reach and highly efficient and effective publishing systems and processes. With offices in the UK, US, Germany, China and Japan, and staff in many other locations including Mexico and Russia, we serve researchers in the physical and related sciences in all parts of the world.
IOP Publishing is a wholly owned subsidiary of the Institute of Physics. The Institute is a leading scientific society promoting physics and bringing physicists together for the benefit of all. Any profits generated by IOP Publishing are used by the Institute to support science and scientists in both the developed and developing world. Go to ioppublishing.org.
The Institute of Physics
The Institute of Physics is a leading scientific society. We are a charitable organisation with a worldwide membership of more than 50,000, working together to advance physics education, research and application. We engage with policymakers and the general public to develop awareness and understanding of the value of physics and, through IOP Publishing, we are world leaders in professional scientific communications. Visit us at http://www.iop.org
Researchers strike gold with nanotech vaccine
2013-06-26
ELSE PRESS RELEASES FROM THIS DATE:
Death rates from heart disease continue to decline in most of the EU
2013-06-26
Death rates from heart disease in the European Union have more than halved in many countries since the early 1980s, according to new research published online today (Wednesday) in the European Heart Journal [1]. In the majority of countries, there have been ongoing steady reductions in heart disease death rates in both sexes and most age groups, including among younger people, despite increases in obesity and diabetes during this time. However, heart disease remains a leading cause of death in Europe.
The authors of the study say their analysis shows little evidence ...
Study ranks social contacts by job and social group in bid to fight infectious diseases
2013-06-26
In the light of Novel Corona Virus, concerns over H7N9 Influenza in S.E. Asia, and more familiar infections such as measles and seasonal influenza, it is as important as ever to be able to predict and understand how infections transmit through the UK population.
Researchers at the University of Warwick and University of Liverpool have mapped the daily contact networks of thousands of individuals to shed light on which groups may be at highest risk of contracting and spreading respiratory diseases.
These scientists used an anonymous web and postal survey of 5,027 UK residents ...
Overweight causes heart failure -- large study with new method clarifies the association
2013-06-26
An international research team led by Swedish scientists has used a new method to investigate obesity and overweight as a cause of cardiovascular disease. Strong association have been found previously, but it has not been clear whether it was overweight as such that was the cause, or if the overweight was just a marker of another underlying cause, as clinical trials with long-term follow-ups are difficult to implement.
A total of nearly 200,000 subjects were included in the researchers' study of the causality between obesity/overweight and diseases related to cardiovascular ...
Cutlery: Do size, weight, shape and color matter?
2013-06-26
The appearance of cutlery can affect perception of a food's taste, reports BioMed Central's open access journal Flavour. Food tastes saltier when eaten from a knife, and denser and more expensive from a light plastic spoon. Taste was also affected by the color of the cutlery.
The crockery we use has been shown to alter our perception of food and drink. Beverages in cold colored glasses were rated more refreshing and the weight and color of a plate can alter how dense, salty or sweet food tastes. In this study, researchers from the University of Oxford demonstrated that ...
Study shows heart failure survivors at greater risk for cancer
2013-06-26
WASHINGTON (June 25, 2013) — Heart failure patients are surviving more often with the heart condition but they are increasingly more likely to be diagnosed with cancer, a trend that could be attributed to increased surveillance, side effects of treatments, or other causes, according to a study published online today in the Journal of the American College of Cardiology.
"Heart failure patients are not only at an increased risk for developing cancer, but the occurrence of cancer increases mortality in these patients," explained Dr. Veronique Roger, MD, director of the Mayo ...
A deep brain disorder
2013-06-26
A group of investigators from San Diego State University's Brain Development Imaging Laboratory are shedding a new light on the effects of autism on the brain.
The team has identified that connectivity between the thalamus, a deep brain structure crucial for sensory and motor functions, and the cerebral cortex, the brain's outer layer, is impaired in children with autism spectrum disorders (ASD).
Led by Aarti Nair, a student in the SDSU/UCSD Joint Doctoral Program in Clinical Psychology, the study is the first of its kind, combining functional and anatomical magnetic ...
Symptoms of Prader-Willi syndrome associated with interference in circadian, metabolic genes
2013-06-26
(SACRAMENTO, Calif.) — Researchers with the UC Davis MIND Institute and Agilent Laboratories have found that Prader-Willi syndrome — a genetic disorder best known for causing an insatiable appetite that can lead to morbid obesity — is associated with the loss of non-coding RNAs, resulting in the dysregulation of circadian and metabolic genes, accelerated energy expenditure and metabolic differences during sleep.
The research was led by Janine LaSalle, a professor in the UC Davis Department of Medical Microbiology and Immunology who is affiliated with the MIND Institute. ...
Laser guided codes advance single pixel terahertz imaging
2013-06-26
VIDEO:
A new method for single pixel terahertz (THz) imaging developed by Boston College researchers uses a set of instructions delivered by a laser beam to tune THz waves in order...
Click here for more information.
CHESTNUT HILL, MA (June 25, 2013) – The universe is awash in terahertz (THz) waves, as harmless as they are abundant. But unlike other regions of the electromagnetic spectrum, THz has proven to be extremely difficult to manipulate in order to capture novel images ...
Blind(fold)ed by science: Study shows the strategy humans use to chase objects
2013-06-26
COLUMBUS, Ohio—A new study has found that chasing down a moving object is not only a matter of sight or of sound, but of mind.
The study found that people who are blindfolded employ the same strategy to intercept a running ball carrier as people who can see, which suggests that multiple areas of the brain cooperate to accomplish the task.
Regardless of whether they could see or not, the study participants seemed to aim ahead of the ball carrier's trajectory and then run to the spot where they expected him or her to be in the near future. Researchers call this a "constant ...
Immunohistochemistry effectively detects ALK rearrangement
2013-06-26
DENVER – ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (NSCLC). It defines a distinct molecular subset of NSCLC, in particular adenocarcinoma that can benefit by the treatment of ALK-inhibitors. Development of robust and reliable laboratory tests for predictive biomarkers is essential to select appropriate patients for targeted therapy.
Researchers from the Chinese University of Hong King evaluated the practical usefulness of immunohistochemistry to detect ALK expression as a reliable ...